Monthly Archives: October 2013


In the posting at the Department of Health clarified that “if and only if these drugs are used in accordance with their FDA indication solely in the context of a bona fide program for Medication-Assisted Treatment (MAT) for opioid dependence, this would not be considered pain management services and those patients should not be counted as such.”